Advances in top-down proteomics for disease biomarker discovery.
about
Immune-enrichment of insulin in bio-fluids on gold-nanoparticle decorated target plate and in situ detection by MALDI MSDirect detection of peptides and proteins on a microfluidic platform with MALDI mass spectrometry.Identification and imaging of peptides and proteins on Enterococcus faecalis biofilms by matrix assisted laser desorption ionization mass spectrometryLiver proteomics in progressive alcoholic steatosis.Selective and nonselective cleavages in positive and negative CID of the fragments generated from in-source decay of intact proteins in MALDI-MS.Heat shock factor 2 levels are associated with the severity of ulcerative colitisInterface solution isoelectric focusing with in situ MALDI-TOF mass spectrometry.Monitoring therapeutic monoclonal antibodies in brain tumor.Enrichment of phosphorylated peptides and proteins by selective precipitation methods.Analysis of Flexibility of Proteins by means of Positive and Negative Ion MALDI In-Source Decay Mass Spectrometry.Microvesicles/exosomes as potential novel biomarkers of metabolic diseasesBiomarkers intersect with the exposomeProteomic identification of biomarkers of skeletal muscle disorders.Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.Complementary PTM Profiling of Drug Response in Human Gastric Carcinoma by Immunoaffinity and IMAC Methods with Total Proteome Analysis.Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer.PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.DMF-MALDI: droplet based microfluidic combined to MALDI-TOF for focused peptide detectionOn-line electrochemical reduction of disulfide bonds: improved FTICR-CID and -ETD coverage of oxytocin and hepcidin.Why less is more when generating tryptic peptides in bottom-up proteomics.
P2860
Q28818783-4B49B3B4-3CAE-4BC9-99DD-DDA6801E3215Q34357383-71AADAF4-13A3-4064-ACFE-B1C75F76BF57Q34409916-546140E5-8DC7-473E-AA8C-82F19A9CDF14Q34497163-030DCC61-428D-4D9C-8473-E3BCBA4BE536Q35019958-85697864-BBFC-475B-B8D9-8C5650C8EEFCQ35095575-D1C13F69-1A7E-4B33-B0DD-7E1182BC6889Q35161958-391613CA-987D-4E65-A3CE-C6B9035B6CF3Q35498835-A503A08E-5F37-423A-A20E-B90AD8EA87CFQ35542665-E4056CE5-B81D-46BE-82EC-239B7B8A3FE4Q35906829-0E359255-17EF-495B-A57C-C4DA28348912Q36175435-49955631-5378-4D91-ABA1-18923629F7DDQ36607005-D9BCBFA9-AA54-4E83-8881-B208C733958CQ38079622-4C91D7AB-98BC-441F-BD25-4EE8EBF3125CQ38194582-E9CB8D89-8BCB-4CF0-A128-6F68ABA18A5FQ38846152-3C52E23D-31EA-4FB9-A243-1B4A2B6FC15DQ38931288-4BE15EC6-12E9-4744-96DD-202047C8B20EQ39398876-4D67730C-F7AE-450F-9A3D-FC5512353B31Q42339209-46D69AA4-3CB4-4636-A39C-3723E2A12956Q42873042-42D67A7E-FE34-4B6C-A136-ED6E237FA894Q44184234-AC1D6AFE-6B4F-46DA-B295-71074154E669
P2860
Advances in top-down proteomics for disease biomarker discovery.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Advances in top-down proteomics for disease biomarker discovery.
@ast
Advances in top-down proteomics for disease biomarker discovery.
@en
type
label
Advances in top-down proteomics for disease biomarker discovery.
@ast
Advances in top-down proteomics for disease biomarker discovery.
@en
prefLabel
Advances in top-down proteomics for disease biomarker discovery.
@ast
Advances in top-down proteomics for disease biomarker discovery.
@en
P1476
Advances in top-down proteomics for disease biomarker discovery
@en
P2093
David Calligaris
P304
P356
10.1016/J.JPROT.2011.03.030
P577
2011-04-06T00:00:00Z